About MUSC Hollings Cancer Center

MUSC Hollings Cancer Center is a premier academic cancer center and South Carolina's only National Cancer Institute (NCI)-designated cancer center. Based in Charleston, it is part of the Medical University of South Carolina, an academic health system founded in 1824. Hollings provides comprehensive cancer care—from prevention and screening to diagnosis, treatment, and survivorship—integrated with groundbreaking clinical and translational research. With a workforce of 5,001-10,000, it operates as a large-scale regional referral hub, combining a high-volume clinical practice with a mission to advance cancer science.

Why AI Matters at This Scale

For a large academic medical center like Hollings, AI is not a futuristic concept but a present-day imperative to manage complexity and personalize care. Its scale generates vast, multidimensional data from electronic health records (EHRs), genomic sequencers, and medical imaging archives. Manually synthesizing this data for insights is impossible. AI offers the tools to unlock patterns within this data, transforming operational efficiency and, most critically, patient outcomes. At this size, the institution has the capital and technical talent to invest in AI infrastructure, but it also faces the acute challenge of integrating new technologies into legacy clinical workflows without disrupting care. Successfully harnessing AI can solidify its leadership in precision oncology, improve population health, and create a sustainable model for cutting-edge research and care delivery.

Concrete AI Opportunities with ROI Framing

1. Enhanced Diagnostic Accuracy with AI Imaging: Deploying deep learning algorithms to analyze mammograms, CT scans, and digital pathology slides can assist radiologists and pathologists in detecting malignancies earlier and with greater consistency. The ROI is twofold: clinical (improved early-stage detection rates boost survival odds) and operational (reduced interpretation time allows specialists to focus on complex cases).

2. Predictive Analytics for Patient Management: Implementing models that continuously analyze EHR data (vitals, lab results, medications) can predict high-risk events like sepsis onset or unplanned readmissions. By alerting care teams to intervene proactively, Hollings can improve patient safety, reduce length of stay, and avoid significant penalty costs associated with hospital-acquired conditions and readmissions.

3. Optimizing Clinical Trial Operations: Using natural language processing (NLP) to automatically screen patient records against complex trial eligibility criteria can dramatically accelerate enrollment for oncology trials. This increases trial throughput, brings novel therapies to patients faster, and enhances the center's research revenue and prestige, directly supporting its NCI designation.

Deployment Risks Specific to This Size Band

Large organizations like Hollings face unique scaling risks. Integration Complexity is paramount; layering AI onto entrenched EHR systems (like Epic or Cerner) requires robust APIs and can create data silos if not managed centrally. Change Management across thousands of clinical staff is daunting; AI tools must be seamlessly embedded into workflows to avoid alert fatigue and ensure adoption. Data Governance becomes critical—ensuring data quality, standardization, and HIPAA-compliant security across numerous departments requires a unified strategy. Finally, Regulatory and Validation Hurdles for clinical AI are significant, requiring rigorous internal validation and potential FDA clearance, which demands substantial investment and time before realizing benefits.